CUE
Cue Biopharma, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website cuebiopharma.com
- Employees(FY) 51
- ISIN US22978P1066
Performance
-10.7%
1W
+14.38%
1M
-21.92%
3M
-28.15%
6M
-35.23%
YTD
-57.78%
1Y
Profile
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops injectable biologics to selectively engage and modulate tumor-specific T cells within the body to treat a range of cancers, chronic infectious diseases, and autoimmune diseases. Its lead drug product candidate is CUE-101, a fusion protein biologic designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company is also developing CUE-102 targets Wilms' Tumor 1 protein in various cancers; CUE-103, a CUE-100 series drug product candidate with Immuno-STAT targeting the KRAS G12V mutation, as well as cancer antigen MAGE-A4; and Neo-STAT and RDI-STAT programs outside of oncology, including CUE-200, CUE-300, and CUE-400 series. It has collaboration agreements with Merck Sharp & Dohme Corp. for the research and development of its proprietary biologics that target various autoimmune disease indications; and LG Chem, Ltd. for the development of Immuno-STATs focused in the field of oncology. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.
Technical Analysis of CUE 2024-05-10
Overview:
In the last 5 trading days, the stock has shown fluctuations in price and volume. The trend indicators suggest a mixed sentiment, with the Moving Average Convergence Divergence (MACD) showing a slight positive trend. Momentum indicators indicate a weakening trend, while volatility indicators show fluctuating price bands. Volume indicat...
Recent News & Updates
- 2024-05-09 11:54
- 2024-05-09 04:05
- 2024-05-07 20:00
- 2024-05-06 20:00
- 2024-04-24 21:35
- 2024-04-23 22:01
- 2024-04-14 21:55
- 2024-04-08 19:36
Q4 2023 Cue Biopharma Inc Earnings Call(Yahoo Finance)
- 2024-04-08 15:02
- 2024-04-08 04:05
- 2024-04-02 01:53
- 2024-04-01 20:00
Cue Biopharma to Host Business Update Call and Webcast(Globenewswire)
- 2024-02-28 21:00
- 2024-02-05 19:00
- 2023-12-13 18:04
- 2023-11-21 19:00
- 2023-11-11 23:55
- 2023-11-09 03:05
- 2023-11-06 19:00
- 2023-11-03 00:00
- 2023-11-01 20:00
Cue Biopharma to Host Business Update Call and Webcast(Globenewswire)
- 2023-09-27 17:39
- 2023-09-26 21:05
- 2023-09-25 20:00
- 2023-08-09 22:37
Q2 2023 Cue Biopharma Inc Earnings Call(Yahoo Finance)
- 2023-08-09 22:19
- 2023-08-09 20:28
- 2023-08-09 04:10
- 2023-08-01 20:00
Cue Biopharma to Host Business Update Call and Webcast(Yahoo Finance)
- 2023-06-21 18:40
3 Biotech Stocks to Buy as Companies Ink Major Deals(Yahoo Finance)
Page 1 of 4
previousnext